CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $49,596
- in 12 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,596. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-03 | LINTAL ELLEN M Chief Financial Officer | Grant or award · Options | +50,000 | 50,000 | ||
| 2021-11-30 | LINTAL ELLEN M Chief Financial Officer | Grant or award · Options | +100,000 | 100,000 | ||
| 2020-12-09 | LINTAL ELLEN M Chief Financial Officer | Grant or award · Options | +75,000 | 75,000 | ||
| 2019-12-31 | LINTAL ELLEN M CFO | Grant or award | +3,931 | $0.53 | $2K | 22,892 |
| 2019-12-13 | LINTAL ELLEN M CFO | Grant or award | +4,789 | $0.44 | $2K | 18,961 |
| 2019-11-29 | LINTAL ELLEN M CFO | Grant or award | +5,208 | $0.40 | $2K | 14,172 |
| 2019-11-15 | LINTAL ELLEN M CFO | Grant or award | +4,433 | $0.47 | $2K | 8,964 |
| 2019-10-31 | LINTAL ELLEN M CFO | Grant or award | +4,167 | $0.50 | $2K | 4,531 |
Page 1 of 1 · 8 trades